by EmpathiCSubstanceS | Aug 12, 2022 | Bipolar Disorder, Chronic Pain, Kambo, LSD, MDMA Sassafras Molly, Microdosing, NN-Dimethyltryptamine, OCD, Psilocybin Magic Mushroom, Psychedelic Medicine
COULD AN OVERACTIVE IMMUNE SYSTEM make you depressed? In the late 1990s, psychiatrist Andrew Miller and his colleagues began to notice that patients with cancer, cardiovascular disease, obesity and Crohn’s disease—all conditions that cause higher than normal levels of...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Further research on this direction is needed in order to better understand the properties of tryptamines like DMT and their biophysical effects and implications on human perception and brain communication. Read from original source
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
We conclude that the function of DMT may extend central nervous activity and involve a more universal role in cellular protective mechanisms. Suggestions are offered for future directions of indole alkaloid research in the general medical field. We provide converging...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Most participants reported vivid memories of the encounter experience, which frequently involved communication with something having the attributes of being conscious, benevolent, intelligent, sacred, eternal, and all-knowing. The encounter experience fulfilled a...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Ayahuasca users (n = 527) reported greater well-being than both classic psychedelic users (n = 18,138) and non-psychedelic drug-using respondents (n = 78,236). Ayahuasca users reported less problematic drinking than classic psychedelic users, although both groups...
